403 related articles for article (PubMed ID: 18405471)
21. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.
Lorente L; Lecuona M; Jiménez A; Santacreu R; Raja L; Gonzalez O; Mora ML
Am J Infect Control; 2014 Mar; 42(3):321-4. PubMed ID: 24581021
[TBL] [Abstract][Full Text] [Related]
22. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.
van de Wetering MD; van Woensel JB; Lawrie TA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD003295. PubMed ID: 24277633
[TBL] [Abstract][Full Text] [Related]
25. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?
Saint S; Veenstra DL; Lipsky BA
Infect Control Hosp Epidemiol; 2000 Jun; 21(6):375-80. PubMed ID: 10879567
[TBL] [Abstract][Full Text] [Related]
26. Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients.
Antonelli M; De Pascale G; Ranieri VM; Pelaia P; Tufano R; Piazza O; Zangrillo A; Ferrario A; De Gaetano A; Guaglianone E; Donelli G
J Hosp Infect; 2012 Oct; 82(2):101-7. PubMed ID: 22938728
[TBL] [Abstract][Full Text] [Related]
27. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
Friedman BC; Mian MA; Mullins RF; Hassan Z; Shaver JR; Johnston KK
J Burn Care Res; 2015; 36(4):493-9. PubMed ID: 25407386
[TBL] [Abstract][Full Text] [Related]
28. Types of urethral catheters for management of short-term voiding problems in hospitalised adults.
Brosnahan J; Jull A; Tracy C
Cochrane Database Syst Rev; 2004; (1):CD004013. PubMed ID: 14974052
[TBL] [Abstract][Full Text] [Related]
29. Clinical review: new technologies for prevention of intravascular catheter-related infections.
Cicalini S; Palmieri F; Petrosillo N
Crit Care; 2004 Jun; 8(3):157-62. PubMed ID: 15153233
[TBL] [Abstract][Full Text] [Related]
30. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use.
Marciante KD; Veenstra DL; Lipsky BA; Saint S
Am J Infect Control; 2003 Feb; 31(1):1-8. PubMed ID: 12548250
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
[TBL] [Abstract][Full Text] [Related]
32. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units.
Ramritu P; Halton K; Collignon P; Cook D; Fraenkel D; Battistutta D; Whitby M; Graves N
Am J Infect Control; 2008 Mar; 36(2):104-17. PubMed ID: 18313512
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of antimicrobial-coated central venous catheters for preventing catheter-related blood-stream infections with the implementation of bundles: a systematic review and network meta-analysis.
Wang H; Tong H; Liu H; Wang Y; Wang R; Gao H; Yu P; Lv Y; Chen S; Wang G; Liu M; Li Y; Yu K; Wang C
Ann Intensive Care; 2018 Jun; 8(1):71. PubMed ID: 29904809
[TBL] [Abstract][Full Text] [Related]
34. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
35. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
36. Central venous catheterization: a prospective, randomized, double-blind study.
Mer M; Duse AG; Galpin JS; Richards GA
Clin Appl Thromb Hemost; 2009 Feb; 15(1):19-26. PubMed ID: 18593746
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.
Veenstra DL; Saint S; Sullivan SD
JAMA; 1999 Aug; 282(6):554-60. PubMed ID: 10450717
[TBL] [Abstract][Full Text] [Related]
38. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
[TBL] [Abstract][Full Text] [Related]
39. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection?
McConnell SA; Gubbins PO; Anaissie EJ
Clin Infect Dis; 2003 Jul; 37(1):65-72. PubMed ID: 12830410
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
